GlassScriptPhysician profile
Larry A Whitfield
NPI 1558311605
$1,983.76
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,598 · 2020: $251 · 2021: $51.72 · 2022: $82.72.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $321.00 | 2019-2020 | |
| Novo Nordisk INC | $201.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $200.27 | 2019-2020 | |
| Insulet Corporation | $175.95 | 2019-2022 | |
| Corcept Therapeutics | $139.87 | 2019-2020 | |
| Abbvie INC. | $136.01 | 2019-2020 | |
| Amgen INC. | $131.60 | 2019-2020 | |
| Lilly USA, LLC | $94.60 | 2019-2022 | |
| Shire North American Group INC | $77.77 | 2019 | |
| Abbott Laboratories | $73.12 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $60.72 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $59.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.09 | 2019 | |
| Janssen Pharmaceuticals, INC | $51.44 | 2019 | |
| Radius Health, INC. | $42.80 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $34.62 | 2019 | |
| Ibsa Pharma INC. | $31.46 | 2019 | |
| Medtronic Minimed, INC. | $28.85 | 2019-2020 | |
| Dexcom, INC. | $27.31 | 2019 | |
| Amarin Pharma, INC. | $20.83 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $17.16 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Whitfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.